Guardant Health Receives Investigational Device Exemption Approval from[...]
Study Demonstrates Potential for the Guardant360 Assay® to Predict[...]
Guardant Health Database Reveals Potential of Targeted Therapy[...]
04/26/2024 | Press release | Distributed by Public on 04/26/2024 06:36
Please select the service you want to use:
Smartlinks | Myomo Inc. | News | Health | Company News | Shareholders | Shareholder Meeting | Proxy Statements | Investment Funds | Securities Issuers | Medical Supplies and Equipment Companies | New York Stock Exchange (NYSE) | Stuttgart Stock Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact